Skip to content

Create your Customized Agenda!

NASH 2020 Agenda at a Glance

A Day by Day Guide:

Monday, May 4 - Focused Discussion Day

Mechanistic Science Deep Dives

Workshop A: Epigenetic Mechanisms Governing Liver Fibrogenesis in NASH

Workshop B: Inflammation & Inflammasome Modulation to Treat NASH & Liver Fibrosis 

New to NASH

Workshop C: Assessing the Translational Relevance & Robustness of Preclinical Modalities

Workshop D: Getting to Grips with the Non-Invasive Evaluation of NAFLD & NASH

Further than NASH

Workshop E: Understanding Hepatocellular Carcinoma as an Extension of NASH Cirrhosis (Including Keynote Speakers) 

Workshops

Workshop G: Drug Safety in NASH: Drugging an Impaired Liver

Workshop H: Pediatric NAFLD/ NASH Drug Development: Regulatory Guidelines, Challenges& Opportunities 

Tuesday, May 5 - Scientific Program Day 1

Plenary Stream 

Discovery Science Stream

Plenary Stream 

Plenary Stream 

Translational Drug Development Stream

Plenary Stream 

Plenary Stream 

Non-Invasive Biomarkers Stream

Plenary Stream 

Plenary Stream 

Clinical Drug Development Stream

Plenary Stream 

Wednesday, May 6 - Scientific Program Day 2

Plenary Stream 

Discovery Science Stream

Plenary Stream

Plenary Stream 

Translational Drug Development Stream

Plenary Stream 

Plenary Stream 

Non-Invasive Biomarkers Stream

Plenary Stream

Plenary Stream

Clinical Drug Development Stream

Plenary Stream

Thursday, May 7 - Forward Thinking Seminar Day

Further than NASH

Full Day Seminar A: NASH & Wider Fibrosis Seminar - Overlap and relationships across organ-specific pathological fibrosis, and lessons learned from other fibrotic disease clinical drug development and regulatory intelligence

Next Steps

Full Day Seminar B: Uptake of Drugs to Market Seminar - Understanding key considerations from pharma and payers, and evaluating consequences of change to market opportunity and access for NASH